Selective serotonin reuptake inhibitors suicidality from

Gunnell, D., Saperia, J., Ashby, D. 2005, Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults meta-analysis of dmg company data from placebo controlled, randomised controlled trials submitted to the MHRA s safety review, Br.Med.f, vol. 330, no. 7488, p. 385. 

Fluoxetine and other selective serotonin reuptake inhibitors (SSRIs) have been associated with increasing suicidal ideation in some populations of patients. Recent studies have led the British Department of Health to warn physicians against using paroxetine off label. Fluoxetine was specifically exempted from this recommendation. Long-term studies of patients with depression who were treated with fluoxetine have shown it to be fairly well tolerated. Primary adverse effects include nausea (23%), headache (21%), and insomnia (20%). 

---